Non-steroidal anti-inflammatory drugs and cancer risk in women: Results from the Women's Health Initiative-Reference-Cited by-同舟云学术

Non-steroidal anti-inflammatory drugs and cancer risk in women: Results from the Women's Health Initiative

Published:2014-03-20 Issue:8 Volume:135 Page:1869-1883
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Brasky Theodore M.¹²,Liu Jingmin³,White Emily²⁴,Peters Ulrike²,Potter John D.²⁵,Walter Roland B.²⁴⁶,Baik Christina S.²,Lane Dorothy S.⁷,Manson JoAnn E.⁸,Vitolins Mara Z.⁹,Allison Matthew A.¹⁰,Tang Jean Y.¹¹,Wactawski-Wende Jean¹²

Affiliation:

1. Department of Internal Medicine Division of Cancer Prevention and Control; The Ohio State University College of Medicine; Columbus OH

2. Cancer Prevention Program, Fred Hutchinson Cancer Research Center; Seattle WA

3. Fred Hutchinson Cancer Research Center, WHI Clinical Coordinating Center; Seattle WA

4. Department of Epidemiology; University of Washington; Seattle WA

5. Centre for Public Health Research; Massey University; Wellington New Zealand

6. Division of Hematology/Department of Medicine; University of Washington; Seattle WA

7. Department of Preventive Medicine; Stony Brook University School of Medicine; Stony Brook NY

8. Harvard Medical School and Brigham and Women's Hospital; Department of Medicine; Boston MA

9. Division of Public Health Sciences; Wake Forest School of Medicine; Winston-Salem NC

10. Department of Family and Preventive Medicine Division of Preventive Medicine; University of California-San Diego School of Medicine; San Diego CA

11. Department of Dermatology; Stanford University School of Medicine; Redwood City CA

12. Department of Social and Preventive Medicine; University at Buffalo; SUNY Buffalo NY

Funder

U.S. Department of Health and Human Services

National Cancer Institute

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference44 articles.

1. Aspirin and cancer risk: a quantitative review to 2011;Bosetti;Ann Oncol,2012

2. Effects of regular aspirin on long-term cancer incidence and metastasis: a systematic comparison of evidence from observational studies versus randomised trials;Algra;Lancet Oncol,2012

3. Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials;Rothwell;Lancet,2011

4. Short-term effects of daily aspirin on cancer incidence, mortality, and non-vascular death: analysis of the time course of risks and benefits in 51 randomised controlled trials;Rothwell;Lancet,2012

5. Effect of daily aspirin on risk of cancer metastasis: a study of incident cancers during randomised controlled trials;Rothwell;Lancet,2012

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of aspirin in the prevention of pancreatic cancer: A nested case-control study in the UK Biobank;Pancreatology;2024-09

2. Analysis of naproxen activation of cell death pathways in Colo320 cells;Molecular and Clinical Oncology;2024-07-03

3. Use of Nonsteroidal Anti-Inflammatory Drugs and Pancreatic Cancer Risk in the Women’s Health Initiative;Cancer Epidemiology, Biomarkers & Prevention;2024-06-20

4. Association between use of low-dose aspirin and detection of colorectal polyps and cancer in a screening setting;Digestive and Liver Disease;2023-08

5. Modification of the Association Between Frequent Aspirin Use and Ovarian Cancer Risk: A Meta-Analysis Using Individual-Level Data From Two Ovarian Cancer Consortia;Journal of Clinical Oncology;2022-12-20